Abstract
Regional differences in the modulation of [3H] muscimol binding to GABAA receptor complexes by kavapyrones, compounds of the rhizome of the plantPiper methysticum which possess sedative activity, were demonstrated using membrane fractions obtained from target brain centers of kavapyrone action: hippocampus (HIP), amygdala (AMY) and medulla oblongata (MED), and from brain centers outside the main kavapyrone effects as frontal cortex (FC) and cerebellum (CER). The kava extract enhanced the binding of [3H] muscimol in a concentration-dependent manner with maximal potentiation of 358% over control in HIP followed by AMY and MED (main target brain centers). Minimal stimulation was observed in CER followed by FC. In contrast, apart from CER, the potency of kavapyrones was similar in the brain areas investigated with EC50 values ranging between 200 and 300 µM kavapyrones. Scatchard analysis revealed that the observed effects of kavapyrones were due to an increase in the number of binding sites (Bmax), rather than to a change in affinity. At a kavapyrone concentration of 500 µM the order of enhancement in Bmax was HIP=AMY>MED>FC>CER. When kavapyrones are included together with pentobarbital or HPO the two classes of compounds produced a more than additive, i.e., synergetic effect on [3H] muscimol binding. Our findings suggest that one way kavapyrones might mediate sedative effects in vivo is through effects on GABAA receptor binding.
Similar content being viewed by others
References
Backhauß C, Krieglstein J (1992) Extract of kava (Piper methysticum) and its methysticin constituents protect brain tissue against ischemic damage in rodents. Eur J Pharmacol 215:265–269
Buckley JP, Furgiuele AR, O'Hara MJ (1967) Pharmacology of kava. In: Efron KH, Holmstedt B, Kline NS (eds) Ethnopharmacology search for psychoactive drugs. Raven Press, New York pp 141–151
Davis LP, Drew CA, Duffield P, Johnston GAR, Jamieson DD (1992) Kava pyrones and resin: studies on GABAA, GABAB and benzodiazepine binding sites in rodent brain. Pharmacol Toxicol 71:120–126
Diaz-Arauzo H, Koehler KF, Hagen TJ, Cook J (1991) Synthetic and computer assisted analysis of the pharmacophore for agonists at benzodiazepine receptors. Life Sci 49:207–216
Holm U, Staedt U, Heep J, Kortsik C, Behne F, Kaske A, Mennicke I (1991) Studies on the profile of neurophysiological effects of D,L-kavain/cerebral sites of action and sleep-wakefulnessrhythm in animals. Drug Res 41 [II]:673–683
Jussofie A (1993a) A new highly sensitive procedure-a prerequisite to evaluate the density of GABAA receptors and to study their allosteric properties in distinct areas of rat brain. Biol Chem Hoppe-Seyler 374:61–68
Jussofie A (1993b) Brain region-specific effects of neuroactive steroids on the affinity and density of the GABA-binding site. Biol Chem Hoppe-Seyler 374:265–270
Jussofie A (1993c) Brain area specific differences in the effects of neuroactive steroids on the GABAA receptor complexes following acute treatment with anaesthetically active steroids. Acta Endocrinol 129:480–485
Keledjian J, Duffield PH, Jamieson DD, Lidgard RO, Duffield AM (1988) Uptake into mouse brain of four compounds present in the psychoactive beverage kava. J Pharm Sci 77:1003–1006
Keller F, Klohs MW (1963) A review of the chemistry and pharmacology of the constituents ofPiper methysticum. Lloydia 26:1–15
Klohs MW, Keller F, Williams RE, Tokes M, Cronheim GE (1959) A Chemical and pharmacological investigation ofPiper methysticum Forst. J Med Pharm Chem 1:95–103
Kretzschmar R, Teschendorf HJ (1974) Pharmacologische Untersuchungen zur sedativ-tranquilisierenden Wirkung des Rauschpfeffers (Piper Methysticum Forst.) Chemiker-Zeitung 98:24–28
Kretzschmar R, Teschendorf HJ, Ladous A, Ettehadieh D (1971) On the sedative action of the kava rhizome (piper methyst). Acta Pharmacol Toxicol 29 [suppl. 4]:26
Koenig JA, Martin IL (1992) Effect of free fatty acids on GABAA receptor ligand binding. Biochem Pharmacol 44:11–153
Laurie DJ, Seeburg PH, Wisden W (1992) The distribution of 13 GABAA receptor subunit mRNAs in the rat brain. II. olfactory bulb and cerebellum. J Neurosci 12:1063–1076
Liljequist S, Tabakoff B (1993) Bicuculline-produced regional differences in the modulation of35S-TBPS binding by GABA, pentobarbital and diazepam in mouse cerebellum and cortex. J Pharmacol Exp Ther 264:638–647
Majewska DM (1992) Neurosteroids: endogenous bimodal modulators of the GABAA receptor. Mechanism of action and physiological significance. Prog Neurosci 38:379–395
Massotti M, Schlichting JL, Antonacci MD, Giusti P, Memo M, Costa E, Guidotti A (1991) Gamma-aminobutyric acidA receptor heterogeneity in rat central nervous system: studies with clonazepam and other benzodiazepine ligands. J Pharmacol Exp Ther 256:1154–1160
Meyer HJ (1962) Pharmakologie der wirksamen Prinzipien des Kava-Rhizoms. Arch Int Pharmacodyn 138:505–536
Meyer HJ (1979) Pharmacology of kava. In: Efron KH, Holmstedt B, Kline N (eds) Ethnopharmacology search for psychoactive drugs. Raven Press, New York, pp 133–140
Miller KW (1985) The nature of the site of general anesthesia. Int Rev Neurobiol 27:1–61
Olsen RW, Snowman AM (1982) Chloride-dependent enhancement by barbiturates of gamma-aminobutyric acid receptor binding. J Neurosci 2:1812–1823
Olsen RW, Tobin AJ (1990) Molecular biology of GABAA receptors. FASEB J 4:1469–1480
Peters JA, Kirkness EF, Callachan J, Lambert JJ, Turner AJ (1988) Modulation of the GABAA receptor by depressant barbiturates and pregnane steroids. Br J Pharmacol 94:1257–1269
Rasmussen AK, Scheline RR, Solheim E (1979) Metabolism of some kavapyrones in rat. Xenobiotica 9:1–16
Sapp DW, Witte U, Turner DM, Longoni B, Kokka N, Olsen RW (1992) Regional variation in steroid anesthetic modulation of [35S] TBPS binding to gamma-aminobutyric acidA receptors in rat brain. J Pharmacol Exp Ther 262:801–808
Scatchard G (1949) The attractions of proteins for small molecules and ions. Ann NY Acad Sci 51:600–672
Schumacher M, McEwen BS (1989) Steroid and barbiturate modulation of the GABAa receptor. Mol Neurobiol 3:275–304
Sieghart W (1992) GABAA receptors: ligand-gated Cl− ion channels modulated by multiple drug-binding sites. Trends Biochem Sci 13:146–150
Simmonds MA, Turner JP (1987) Potentiators of responses to activation of gamma-aminobutyric acid (GABAA) receptors. Neuropharmacology 26:923–930
Spree MH, Croy H-H (1992) Antares-ein standardisiertes Kava-Kava-Präparat mit dem Spezialextrakt KW 1491, Der Kassenarzt (Deutsches Ärztemagazin) 17:44–51. Stephenson FA (1988) Understanding the GABAA receptor: a chemically gated ion-channel. Biochem J 249:21–32
Study RE, Barker JL (1981) Diazepam and pentobarbital: fluctuation analysis reveals different mechanisms for potentiation of gamma-aminobutyric acid responses in cultured central neurons. Proc Natl Acad Sci USA 78:7180–7184
Wisden W, Laurie DJ, Monyer H, Seeburg PH (1992) The distribution of 13 GABAA receptor subunit mRNAs in the rat brain. I. telencephalon, diencephalon, mesencephalon. J Neurosci 12:1063–1076
Yang JSF, Olsen RW (1987) Gamma-amino-butyric acid receptor binding in fresh mouse brain membranes at 22°C: ligand-induced changes in affinity. Mol Pharmacol 32:266–277
Author information
Authors and Affiliations
Additional information
This paper contains essential parts of the dissertation by Annette Schmiz
Rights and permissions
About this article
Cite this article
Jussofie, A., Schmiz, A. & Hiemke, C. Kavapyrone enriched extract fromPiper methysticum as modulator of the GABA binding site in different regions of rat brain. Psychopharmacology 116, 469–474 (1994). https://doi.org/10.1007/BF02247480
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02247480